Jenkem Technology Co Ltd
SSE:688356

Watchlist Manager
Jenkem Technology Co Ltd Logo
Jenkem Technology Co Ltd
SSE:688356
Watchlist
Price: 57.66 CNY -1.44% Market Closed
Market Cap: 3.5B CNY
Have any thoughts about
Jenkem Technology Co Ltd?
Write Note

Jenkem Technology Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jenkem Technology Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Jenkem Technology Co Ltd
SSE:688356
Total Liabilities & Equity
ÂĄ1.3B
CAGR 3-Years
14%
CAGR 5-Years
44%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Liabilities & Equity
ÂĄ33B
CAGR 3-Years
17%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Liabilities & Equity
ÂĄ17B
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Liabilities & Equity
ÂĄ48.2B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
19%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Liabilities & Equity
ÂĄ54.4B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Liabilities & Equity
ÂĄ1.4B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jenkem Technology Co Ltd
Glance View

Market Cap
3.5B CNY
Industry
Pharmaceuticals

Jenkem Technology Co., Ltd. engages in the research, development, production and sales of medical polyethylene glycol (PEG) and its active derivatives. The company is headquartered in Beijing, Beijing and currently employs 208 full-time employees. The company went IPO on 2020-08-26. The firm's primary products are medical polyethylene glycol and its active derivatives, which are used in research, development and production of drugs and medial devices, scientific research institutions and other fields. The firm is also involved in providing technical services, including patent and non-patent technology licensing services, as well as research and development services.

Intrinsic Value
71.09 CNY
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Jenkem Technology Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
1.3B CNY

Based on the financial report for Dec 31, 2023, Jenkem Technology Co Ltd's Total Liabilities & Equity amounts to 1.3B CNY.

What is Jenkem Technology Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
44%

Over the last year, the Total Liabilities & Equity growth was 3%. The average annual Total Liabilities & Equity growth rates for Jenkem Technology Co Ltd have been 14% over the past three years , 44% over the past five years .

Back to Top